Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
wu, qianhong
TB-TRUST, NCT03867136: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)	Completed	4	354	RoW	PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter Regimen	Huashan Hospital	Multidrug Resistant Tuberculosis	08/24	08/24
TB-TRUSTplus, NCT04717908: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS	Completed	N/A	89	RoW	Bedaquiline, BDQ, Pyrazinamide, PZA, Linezolid, LZD, Cycloserine, Cs, Clofazimine, CFZ	Huashan Hospital	Multidrug Resistant Tuberculosis	06/24	06/24